203 related articles for article (PubMed ID: 16524460)
1. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.
Kitkumthorn N; Yanatatsanajit P; Kiatpongsan S; Phokaew C; Triratanachat S; Trivijitsilp P; Termrungruanglert W; Tresukosol D; Niruthisard S; Mutirangura A
BMC Cancer; 2006 Mar; 6():55. PubMed ID: 16524460
[TBL] [Abstract][Full Text] [Related]
2. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
[TBL] [Abstract][Full Text] [Related]
3. CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions.
Chujan S; Kitkumthorn N; Siriangkul S; Mutirangura A
Asian Pac J Cancer Prev; 2014; 15(18):7971-5. PubMed ID: 25292097
[TBL] [Abstract][Full Text] [Related]
4. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
5. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
6. Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Zhang L; Hu D; Wang S; Zhang Y; Pang L; Tao L; Jia W
Gene; 2020 Jan; 723():144142. PubMed ID: 31589957
[TBL] [Abstract][Full Text] [Related]
7. Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang.
Zuo Q; Zheng W; Zhang J; Pan Z; Liu Y; Long H; Fan P; Guo C; Li F; Shao R
Int J Biol Markers; 2014 Dec; 29(4):e354-62. PubMed ID: 25198553
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer.
Yanatatsaneejit P; Mutirangura A; Kitkumthorn N
Int J Gynecol Cancer; 2011 Jul; 21(5):902-6. PubMed ID: 21412159
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
[TBL] [Abstract][Full Text] [Related]
10. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions.
Lattario F; Furtado YL; Fonseca R; Silveira FA; do Val IC; Almeida G; Carvalho MG
Int J Gynecol Cancer; 2008; 18(4):785-9. PubMed ID: 17868341
[TBL] [Abstract][Full Text] [Related]
13. TIMP-2 gene methylation in cervical precursor and invasive lesions.
Furtado Y; Almeida G; Silveira FA; Silva KS; Maldonado P; do Val IC; Cavalcanti S; L MA; Carvalho Mda G
Exp Mol Pathol; 2015 Feb; 98(1):119-23. PubMed ID: 25579181
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
16. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
[TBL] [Abstract][Full Text] [Related]
17. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
18. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
19. P16 methylation is an early event in cervical carcinogenesis.
Huang LW; Pan HS; Lin YH; Seow KM; Chen HJ; Hwang JL
Int J Gynecol Cancer; 2011 Apr; 21(3):452-6. PubMed ID: 21436693
[TBL] [Abstract][Full Text] [Related]
20. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
